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1. Introduction 
Decisions associated to ovarian stimulation approach are an essential component of 
medically assisted reproduction (MAR). Considerable amount of research in this field has 
enhanced our understanding of certain biological phenomena taking place in the process 
and also brought along novel means of ovarian stimulation. Nevertheless, there is still not 
enough evidence to suggest the optimal number of oocytes collected at retrieval in order to 
predict the occurrence of successful pregnancy and most importantly, birth of a live baby. 
First, this chapter will describe certain historical developments in MAR. Next, current 
ovarian stimulation protocols and desired aims of modern era ovarian stimulation, embryo 
culture and embryo transfer outcome will be discussed. A single-centre MAR results 
analysis was performed in a ten year span in order to help resolve one of the ultimate 
questions: what is the optimal number of oocytes needed to achieve clinical pregnancy after 
embryo transfer? 
2. Milestones in evolution of ovarian stimulation and embryo transfer 
Ever since the beginnings of MAR, increasing the chance of a live birth has been the most 
important aim of researchers’ efforts. The first successful embryo transfers (ETs) resulting in 
pregnancy by Edwards and Steptoe in the early 1970s were carried out in natural cycles. 
This means that only one oocyte was harvested at follicle aspiration (which was at the time 
performed laparoscopically). Hundred-and-one ETs were attempted before the first 
successful delivery of the world’s first IVF (in vitro fertilization) baby Louise Brown in 1978 
(Edwards & Steptoe, 1980). In these first attempts that paved the way for future extensive 
worldwide MAR success, Edwards and Steptoe described 65 natural cycles that yielded 45 
oocytes from 44 patients and resulted in 3 successful deliveries. Thus, pregnancy rate was 
9.1% and delivery rate 6.8% per oocyte retrieval. 
Since then, research has brought along many improvements to MAR. In the early 1980s, one 
of the most important steps was the introduction of human menopausal gonadotrophin 
(HMG), which allowed for controlled ovarian hyperstimulation (COH) and multiple 
follicular growth. This enabled the retrieval of multiple oocytes at pick-up and thus 
substantially increased the likelihood of successful embryo replacement and subsequent 
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pregnancy. This finding has ignited further research and development that has improved 
gonadotrophin formulation and efficiency, but detailed illustration of this process is beyond 
the scope of this chapter. 
3. Current challenges in ovarian stimulation 
3.1 Ovarian hyperstimulation syndrome 
The development and implementation of gonadotrophins that allowed for controlled 
ovarian hyperstimulation (COH) in MAR has brought along a possibility of potentially life-
threatening complication, namely ovarian hyperstimulation syndrome (OHSS) (Brinsden et 
al., 1995). It has been established that the risk of OHSS increases proportionally with an 
increase in ovarian response to stimulation as measured by the number of ovarian follicles, 
number of retrieved oocytes and serum estradiol concentration on the day of human 
chorionic gonadotrophin (hCG) administration (Asch et al., 1991). In our previous research, 
it has been demonstrated that the risk of OHSS increases with rising number of harvested 
oocytes and the risk is significantly higher in patients with more than ten collected oocytes 
(Reljič et al., 1999). Severe OHSS is a serious and potentially life-threatening complication of 
MAR treatment and has a mean incidence of 1-3% in MAR programmes involving standard 
ovarian stimulation protocols (Fauser et al., 1999). However, to date, there are no reliable 
predictors of its occurrence. Owing to these facts, many investigations in recent decade have 
been aimed towards less aggressive, milder forms of ovarian stimulation and to procedures 
that could eliminate the risk of OHSS (Revelli et al., 2011). 
3.2 Ovarian stimulation strategies 
Ovarian stimulation is the crucial component in medically assisted reproduction. In current 
practice, long acting gonadotrophin-releasing hormone (GnRH) agonist pituitary 
suppression combined with recombinant or purified urinary exogenous follicle stimulating 
hormone (FSH) is the most frequently used stimulation protocol (Macklon et al., 2006). 
However, in light of making MAR more “patient friendly”, there is a recent trend toward 
milder stimulation protocols in order to reduce the chances of complications and not lastly, 
to lower the costs of MAR treatment (Fauser et al., 1999). With the availability of GnRH 
antagonists in ovarian stimulation protocols, administration of FSH can be delayed to mid-
follicular phase, thus reducing the amount of gonadotrophins used for stimulation and 
minimizing exogenous hormonal interferences that are present in conventional hormonal 
stimulation (Fauser & van Heusden, 1997). On the other hand, regarding reduction of OHSS, 
conventional stimulation protocols employing GnRH antagonists allow for substitution of 
human chorionic gonadotrophin (hCG) with GnRH agonist for ovulation triggering. Using 
this procedure, OHSS can be eliminated almost completely even in high responding patients 
with high numbers of retrieved oocytes (Humaidan et al., 2011). 
Despite the novel approaches to ovarian stimulation, the number of retrieved oocytes is still 
considered to be an important prognostic variable in everyday MAR practice.  However, the 
relation between the number of oocytes and MAR outcome is poorly understood as studies 
performed on this subject present with conflicting results (Hamoda et al., 2010; Letterie et 
al., 2005; Meniru et al., 1997; Sunkara et al., 2011; Yoldemir et al., 2010). Moreover, as IVF 
procedures are performed in increasing extent globally, new, restrictive legislation policies 
in certain countries limit the amount of oocytes per cycle that can be used in MAR 
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procedures. Due to the lack of reliable data, experts’ opinions of such legislation effects on 
treatment success are too often contradictory. Thus, further research is needed to establish 
the role of number of harvested oocytes in MAR outcome prediction. 
3.3 Embryo cultivation and transfer strategies 
In the scenario of transfer of more than one embryo, multiple gestations are the most 
common complication of pregnancies achieved through MAR. Thus, in recent times, 
scientific societies have propagated the idea that the goal of medically assisted 
procreation must be the achievement of a singleton pregnancy (European Society of 
Human Reproduction and Embryology [ESHRE] Task Force on Ethics and Law, 2003). 
The simplest way of reducing multiple gestation incidences is strict implementation of 
single embryo transfer (SET) strategy. However, this is related to significant declines of 
pregnancy rates. The development of advanced embryo culture media in the past two 
decades have allowed for extended, blastocyst cultivation of the embryos. Following the 
evolution of these media, many have advocated blastocyst transfer mainly due to better 
morphologic embryo assessment possibilities at blastocyst stage compared to cleavage 
stage embryos. Although the opinions on this subject are still not uniform, many recently 
performed studies have demonstrated significantly better outcome after blastocyst 
transfer (Papanikolau et al., 2008). Thus, a recent Cochrane review has shown a significant 
improvement in pregnancy and live birth rates for blastocyst transfer compared to 
transfer of cleavage stage embryos (Blake et al., 2007).  
Currently, increasing number of legislation acts on MAR in developed countries impose 
mandatory single embryo transfer under certain circumstances (mostly in younger 
patients), in order to decrease the incidence of multiple gestations. Thus, the question 
remains; how to select the best embryos in order to achieve the highest success and at the 
same time lower the incidence of multiple gestations? With regards to these facts, 
additional studies should settle the issue in what scenario can the number of oocytes be a 
factor in decision for SET or multiple embryo transfer and whether embryos should be 
transferred at cleavage or blastocyst stage. 
4. Influence of number of retrieved oocytes on embryo transfer success 
A retrospective study of retrieved oocyte number on MAR outcome was performed at 
Department of Reproductive Medicine and Gynaecologic Endocrinology, University Medical 
Centre in Maribor. Totally, 6989 consecutive in vitro fertilisation (IVF) and intracytoplasmic 
sperm injection (ICSI) cycles resulting in follicle aspiration and oocyte pick-up were included. 
Ovarian stimulation protocols with combination of GnRH agonist/GnRH antagonist and 
recombinant FSH (Gonal-f®, Serono International SA, Geneva, Switzerland)/HMG 
(Menopur®, Ferring Pharmaceuticals Inc., Saint-Prex, Switzerland) were used and were 
previously described in detail (Vlaisavljević et al., 2000). Embryo quality was assessed by an 
experienced embryologist at day two and blastocysts were graded according to our 
established grading system at day five after oocyte pick-up (Kovačič et al., 2004). Embryo 
transfer was carried out three or five days after oocyte pick-up. Day five blastocyst transfer 
was performed if more than four fertilised oocytes were obtained and if more than three 
optimal embryos were available on day three according to our standard policies (Kovačič et 
al., 2002). After consultation with the patients, time of embryo transfer could be adjusted to 
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day 3 or day 5 according to doctor-patient agreement. Clinical pregnancy was defined as the 
presence of fetal heartbeat on ultrasound examination at six weeks of gestation. Frozen-
thawed embryo transfer cycles and cycles with preimplantation genetic diagnostics (PGD) or 
in vitro maturated (IVM) oocytes were excluded from the study. 
Patients were stratified according to the number of oocytes collected at retrieval. Categorical 
variables were tested using Chi-Square test. Numerical values were tested bivariately using 
Student’s t-test or Mann-Whitney U test. The analysis of variance test (ANOVA) with Tukey 
HSD or Games-Howell post-hoc test was used for analysing differences in continuous 
variables between groups stratified by the number of retrieved oocytes. To further explore 
the association between the number of oocytes and clinical pregnancy rate, a logistic 
regression model was constructed. The model was adjusted for confounding variables that 
affected pregnancy rate in univariate analysis (the history of previous MAR attempts, age 
and dose of gonadotrophins). Data were analysed using SPSS 17.0 (SPSS Inc., Chicago IL) 
statistical software package. 
4.1 Distribution of retrieved oocytes per cycle 
In 6989 studied cycles, 61793 oocytes were collected at retrieval. The median number of 
retrieved oocytes was 8 [interquartile range (IQR) 4-12] and the median number of embryos 
created was 4 [IQR 2-7]. Figure 1 represents the distribution of collected oocytes in cycles 
resulting in oocyte pick-up. 
 
Fig. 1. Distribution of retrieved oocytes. 
4.2 Outcome of MAR cycles 
Cycles were stratified according to the number of retrieved oocytes. Overall clinical 
pregnancy rate per cycle was 37.1%, calculated pregnancy rate per embryo transfer was 
41.0%. Delivery rates per cycle and per embryo transfer were calculated to be 29.8% and 
32.9%, respectively. Clinical outcomes are summarized in Table 1. 
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No. of oocytes 1-5 6-10 11-15 16-20 >20 TOTAL 
No. of cycles 2396 2405 1269 544 375 6989 
Age (SD) 36.1 (4.6)a 33.8 (4.6)b 32.6 (4.2)c 32.2 (4.4)c 32.0 (4.2)c 34.2 (4.7) 
No of previous MAR 
attempts (SD) 
2.0 (2.4)a 1.6 (2.1)b 1.5 (1.9)bc 1.4 (1.9)c 1.3 (1.6)c 1.7 (2.2) 
No. of oocytes 
collected 
7765 18823 16061 9571 9573 61793 
Fertilised oocytes 
(2PN) 
4910 11552 9668 5686 5510 37326 
Day 2 embryos 4837 11352 9454 5565 5381 36589 
ET(s) 2027 2241 1213 513 332 6326 
Percentage of day 5 
ETs 
14.0%a 69.4%b 86.7%c 92.6%d 94.3%d 58.2% 
Cancelled ET 15.4%a 6.8%b 4.4%c 5.7%bc 11.5%ab 9.5% 
Transferred embryos 3502 4040 2123 828 489 10982 
Cryopreserved 
embryos 
295 2212 2544 1982 2150 9183 
Clinical Pregnancies 532 954 638 286 184 2594 
Avg. Fertilisation rate 75.6%a 77.2%ab 77.6%ab 79.3%ab 83.8%b 77.3% 
Pregnancy rate/cycle 22.2%a 39.7%b 50.3%c 52.6%c 49.1%c 37.1% 
Pregnancy rate/ET 26.3%a 42.6%b 52.6%c 55.8%c 55.4%c 41.0% 
Cycles with blastocyst 
cryopreservation 
8.3%a 38.9%b 58.3%c 73.0%d 83.5%e 37.0% 
abcde Within each category, numbers with different letter superscripts are significantly different from 
each other, numbers with the same letter superscript are not significantly different (p<0.05). 
Table 1. Outcome of MAR treatment according to the number of retrieved oocytes 
4.3 Clinical pregnancy & delivery rates in relation to the number of retrieved oocytes 
Clinical pregnancy and delivery rates were calculated per each number of collected oocytes. 
Clinical pregnancy rate rises constantly to peak at 11-15 oocytes and from then on remains 
constant until it declines slightly at high responders with more than 20 oocytes (Table 1 & 
Figure 2). Nonetheless, there are no statistically significant changes in pregnancy rates in 
groups of patients with more then 11-15 harvested oocytes. However, the risks related to 
ovarian stimulation increase with rising oocyte count, which is partially reflected in higher 
cycle cancellation rates, especially in patients with more than 20 harvested oocytes (Table 1). 
Published data about the number of oocytes influencing embryo transfer outcome are not 
consistent. Whilst some scientists claim that oocyte number plays no role in achievement of 
pregnancy after embryo transfer (Letterie et al., 2005; Yoldemir et al., 2010), others report of 
increasing pregnancy rates with increasing number of oocytes. The optimal numbers 
reported in these studies are usually in the range of 5 to 15 oocytes (van Gast et al., 2006; 
Meniru & Craft, 1997; Timeva et al., 2006). Most of these studies are however single-centre 
analyses performed on a fairly low number of patients. Recently though, Sunkara et al 
performed a large scale review of UK national IVF data and concluded that 15 is the optimal 
number of oocytes to be collected at retrieval (Sunkara et al., 2011). Results of our study that 
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included nearly 7000 cycles suggest that the optimal number of oocytes to aim for at ovarian 
stimulation in order to achieve clinical pregnancy should be between 11 and 15. 
 
Fig. 2. Clinical pregnancy and delivery rates in relation to the number of retrieved oocytes  
4.3.1 Low number of oocytes 
As noted above, pregnancy and delivery rates are significantly lower in cycles where less 
than 5 oocytes are retrieved at pickup. Accordingly, these cycles were analysed more 
thoroughly. Significant changes can be observed in pregnancy rates among each of the 
groups (Table 2). These differences remain significant even after controlling for the age 
factor and history of previous MAR attempts in multivariate analysis. 
It has been demonstrated that low oocyte numbers after ovarian stimulation are related to 
ovarian ageing and the depletion of primordial follicle pool (Tarlatzis et al., 2003). Ovarian 
stimulation for women with low ovarian reserve has remained one of the most frustrating 
aspects of IVF (Revelli et al., 2011). However, direct correlation with pregnancy rate has not 
been thoroughly investigated. 
Low oocyte number coupled with high gonadotrophin dose in conventional stimulation 
methods can imply lower oocyte quality. Furthermore, endometrial quality can also be 
hampered in high-dose stimulating protocols (Gougeon, 1996; Pal et al., 2008). On the other 
hand, higher number of oocytes simply allows for better selection of quality embryos from a 
larger cohort of available embryos (Devreker, 1999; Pal et al., 2008). 
On the opposite, it has been theorised that milder forms of ovarian stimulation allow for 
higher quality oocytes and embryos with lower incidence of chromosome aneuploidies that 
can result in comparable pregnancy rates in spite of the lower number of harvested oocytes 
(Verberg et al., 2009). However, studies on this subject are relatively sparse and a recently 
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performed meta-analysis included only three studies featuring low number of participants 
(Verberg et al., 2009). All of the studies included report of relatively low pregnancy rates, 15-
21%. What is more, the studies did not account for possible added benefits of embryo 
cryopreservation, which could shift the scale to the side of classic ovarian stimulation even 
further if adding freeze-thaw cycles to the analysis. In theory, mild stimulation seems a 
feasible choice that could be especially indicated in poor responding patients. Because of 
lower gonadotrophin dose, higher quality of oocytes and endometrium could be expected. 
But since there is very limited data available, current reports do not provide enough 
supporting evidence and in the end, additional studies are needed in order to define the role 
of mild stimulation protocols in routine MAR treatment. 
Number of oocytes 1 2-3 4-5 TOTAL 
 
No. of cycles 305 983 1108 2396 
 
Age (SD) 37.9 (4.2)a 36.7 (4.4)b 35.2 (4.6)c 36.1 (4.6) p<0.001 
No of previous MAR 
attempts (SD) 
2.0 (2.4)a 2.1 (2.7)a 1.9 (2.2)a 2.0 (2.4) p>0.05 
Gonadotrophin used (IE) 2979a 2789b 2518c 2692 p<0.001 
No of oocytes collected 305 2467 4993 7765 
 
Fertilised oocytes (2PN) 212 1574 3124 4910 
 
Day 2 embryos 205 1532 3100 4837 
 
ET(s) 185 828 1014 2027 
 
Percentage of day 5 ETs 0.5% 3.0% 25.4% 14.0% 
 
Cancelled ET 39.34%a 15.77%b 8.48%c 15.40% p<0.001 
Transferred embryos 186 1368 1948 3502 
 
Cryopreserved embryos 0 41 254 295 
 
Clinical Pregnancies 16 184 332 532 
 
Avg. Fertilisation rate 78.2%a 75.0%a 75.8%a 75.6% p>0.05 
Pregnancy rate/cycle 5.30%a 18.70%b 30.00%c 22.20% p<0.001 
Pregnancy rate/ET 8.70%a 22.20%b 32.70%c 26.30% p<0.001 
Cycles with blastocyst 
cryopreservation 
0%a 3.30%b 15.10%c 8.30% p<0.001 
abc Within each category, numbers with different letter superscripts are significantly different from each 
other, numbers with the same letter superscript are not significantly different. 
Table 2. Cycle characteristics in “poor” and “low” responders (<5 oocytes collected) 
4.4 Effect of age 
Besides the number of oocytes, age was found to be one of the most important factors in 
predicting the success of the started cycle in our data. In further analysis, cycles were stratified 
according to the age of female patients. Advancing age significantly adversely affects the 
outcome of MAR cycles independently of oocyte count. Average clinical pregnancy rate was 
the highest in the youngest group of patients (20-34 years) at 45.6% and decreased to 16.8% in 
women over 40 years of age. On the other hand, mean oocyte count was also significantly 
lower in older women (20-34 years; 10.4 oocytes, 35-37 years; 8.5 oocytes, 38-39 years; 6.9 
oocytes, 40-44 years; 5.7 oocytes, p<0.001). The results are illustrated in Figure 3. 
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Fig. 3. Association between oocyte number and delivery rate stratified by the female 
patient age. 
With ovarian ageing, the depletion of ovarian reserve usually involves adjusting stimulation 
protocols with higher doses of gonadotrophins that result in negative effects as discussed in 
previous topic. Although our study did not consider antral follicle count (AFC) and anti-
Müllerian hormone (AMH) as a measure of ovarian reserve, it can be clearly seen from our 
results that age is independent predictor of lower oocyte count at retrieval. But even in the 
case of normal response to gonadotrophin treatment in older women, pregnancy rates are 
lower compared to younger patients. This could be related to the high proportion of embryo 
aneuploidies in these patients. This problem grows quickly after 40 years of age and after 
the age of 45 the birth of a healthy baby after MAR is very rare in spite of normal ovarian 
reserve tests (Forman et al., 2011). 
4.5 Embryo cryopreservation 
Although the birth of a live baby preceded by the successful achievement of clinical 
pregnancy is the single most important outcome of MAR treatment, several other surrogate 
indicators were evaluated in order to assess the quality of MAR cycles. 
Embryo transfer was performed in 91.5% of cycles after oocyte pick-up. In approximately 
9.5% cycles transfer had to be cancelled. The rate of transfer cancellation is the highest in 
“poor” responding patients and approximately 40% of transfers were cancelled when only 1 
oocyte was retrieved (Table 1 & Table 2). This can be contributed to the fact that there are 
fewer embryos available for transfer and also to the lower quality of oocytes available for 
treatment (Tarlatzis et al., 2003). On the other hand, cycle cancellation again increases 
significantly in high responding patients, with more than 20 oocytes collected at retrieval.  
Together with the higher rate of cycle cancellation, a drop in pregnancy and delivery rates is 
also observed beyond 20 harvested oocytes (Table 1 & Figure 2). In concordance with these 
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results, recently performed studies argue that the simple aim to harvest as many oocytes as 
possible is simply not justified (van der Gast et al., 2006; Sunkara et al., 2011). Our analysis 
has some limitations due to the fact that incidence of OHSS could not be analysed and cycles 
with cryopreservation of the whole embryo cohort due to high OHSS risk could not be 
excluded from the analysis. It could be reasoned that lower pregnancy rates and high 
embryo transfer cancellation can be attributed to ovarian hyperstimulation syndrome risk. 
But considering data in the literature, approximately 15% incidence of OHSS can be 
predicted at 20 collected oocytes and the risk increases with rising oocyte count (Reljič et al., 
1999; Verwoerd et al., 2008). In addition, there is also evidence that high estradiol levels may 
negatively impact developmental potential of the embryos (Ertzeid & Storeng, 2001) and 
interfere with endometrial receptivity in the early luteal phase (Devroey et al., 2004; 
Horcajadas et al., 2008). Thus, pregnancy rates can be hampered in high responders even in 
the absence of ovarian hyperstimulation syndrome risk. 
 
Fig. 4. Association of the number of retrieved oocytes to embryo cryopreservation, 
successful blastocyst culture and proportion of good quality embryos on day two. 
Nonetheless, an increase in proportion of cycles with embryos available for freezing can be 
observed up until ~20 oocytes (Table 1 & Figure 4). The relationship was evident also in 
multivariate analysis after controlling for possible confounding variables (age, history of 
previous MAR attempts and dosage of gonadotrophins). Somewhat lower pregnancy rates 
in these patients could theoretically be recovered in subsequent cryo-thawed cycles. It 
should be noted though, that this group of patients included also couples with cancelled 
embryo transfer and cryopreservation of the whole embryo cohort due to high OHSS risk. 
Due to our study design, linkage between fresh and cryo-thawed cycles was not possible 
and the analysis of cumulative pregnancy rates could not be performed. Our results are 
comparable with findings of the research by Hamoda et al in which there was no increment 
in cycles with available oocytes for freezing beyond 18 harvested oocytes (Figure 4). 
www.intechopen.com
 Advances in Embryo Transfer 48
Furthermore, the storage of high numbers of cryopreserved embryos can also lead to 
logistic, administrative and ethical problems. Even so, in a unit with a successful 
cryopreservation programme, especially with the advances of embryo vitrification, 
cumulative pregnancy rates can be substantially improved (Kolibianakis et al., 2009).  
Additionally, blastocyst transfer was performed significantly more frequently with rising 
number of harvested oocytes. Because day 5 blastocyst transfer allows for enhanced embryo 
selection and can optimize the chance of embryo transfer success (Blake et al., 2007; Kovačič 
et al, 2002; Papanikolaou et al., 2008), further analysis was aimed toward the comparison of 
different embryo cultivation and transfer policies. 
4.6 Embryo cultivation protocol 
Couples were stratified according to the stage at which embryos were replaced in the uterus. 
At blastocyst stage, single embryo or two embryos were transferred, at cleavage stage one to 
three embryos were transferred depending on the age, history of the patients and embryo 
quality. Results of embryo transfer after different protocols are illustrated in Table 3. 
In the beginnings of MAR, cleavage stage embryo transfer was traditionally performed. 
Physiology and energy metabolism of early embryos were not well understood and thus 
media could not be used to culture embryos beyond the four-cell stage. However, with 
scientific advances, new improved, sequential blastocyst media have enabled longer in vitro 
cultivation of embryos (Menezo et al., 1998). There are two central reasons why this should 
theoretically improve embryo transfer results. First of all, it is considered that blastocyst 
transfer mimics natural conception physiology as the embryo travels through Fallopian tubes 
and reaches the uterine cavity no sooner than the fourth day after conception. The uterus 
provides different nutritional conditions for the embryo and this may cause homeostatic stress 
and reduce embryo implantation rates after cleavage stage transfer (Blake et al., 2007). The 
second reason lies in the before mentioned chance of better morphologic selection of the 
embryos at blastocyst stage. However, in our previous studies, it was demonstrated that in the 
case of low number of embryos this advantages did not help to improve success rates of 
embryo transfer. Extended blastocyst culture did not prove to be of any value in improving 
pregnancy rates in the scenario when fewer than three embryos were available at day two after 
oocyte pickup. On the other hand, although transfer cancellation was significantly higher 
when waiting until day five for transfer, pregnancy and delivery rates per started cycle were 
comparable (Kovačič et al., 2002; Vlaisavljević et al., 2001). According to the present study, 
clinical and ongoing pregnancy rates were significantly higher in the case of blastocyst transfer 
compared to day three cleavage stage embryo transfer (52.7% vs. 25.3% and 43.1% vs. 18.6% 
respectively). Even in the multivariable logistic regression model, adjusting for the age of the 
patients and the number of harvested oocytes, these differences remained statistically 
significant. These results should however be interpreted in the light of the fact that these 
groups were composed of patients with uneven characteristics. Generally, patients with less 
than five harvested oocytes and fewer than three embryos on day two that have effectively 
worse prognosis underwent cleavage stage transfer on day three. The number of harvested 
oocytes was significantly lower in day 3 group transfer as compared to day 5. In spite of this, 
considering data in the literature (Blake et al., 2007; Papanikolaou et al., 2008), our data 
confirm that blastocyst transfer provides a higher chance of embryo implantation and 
subsequent clinical pregnancy.   
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Additionally, it can clearly be seen that double blastocyst transfer does not improve 
pregnancy rates compared to transfer of a single blastocyst. This can be observed even when 
analysing only cycles with at least one optimal blastocyst transferred. On the other hand, the 
incidence of twin deliveries rises dramatically with double embryo, especially double 
blastocyst transfer (38.1%). 
 
Day 5 SBT DBT Day 3 SET DET TET TOTAL 
No. of cycles 3572 1452 2120 2647 798 1377 472 6219 
Age (SD) 
32.8 
(4.3) 
31.8 
(4.2)a 
33.4 
(4.3)b 
35.8 
(4.6) 
35.7 
(4.7)c 
35.3 
(4.5)c 
37.5 
(4.3)d  
Avg. no of 
oocytes (SD) 
11.8 
(5.6) 
12.5 
(6.5)a 
11.3 
(5.1)b 
5.2  
(3.7) 
3.5    
(2.8)c 
5.6  
(3.6)d 
6.9  
(4.0)e 
8.8   
(6.1) 
% transfers with 
optimal quality 
blastocyst 
53.2% 60.6% 48.2% 
 
. . . . 
Clinical 
pregnancy/ET 
52.7% 52.2%a 53.1%a 25.3% 15.2%b 30.5%c 27.3%c 41.1% 
Implantation 
rate 
43.9% 53.1%a 37.6%b 16.6% 15.1%cd 19.2%c 11.3%d 31.2% 
Ongoing 
pregnancy/ET 
43.1% 
(625) 
43.1%a 
(912) 
43.2%a 
18.6% 
(92) 
11.6%b 
(313) 
22.8%c 
(84) 
17.9%c 
(1663) 
32.9% 
Twins 24.5% 
(8) 
1.7% 
(303) 
38.1% 
17.6% 
(1)   
1.4% 
(49) 
20.1% 
(19) 
25.3% 
(380) 
22.8% 
Triplets 0.4% 0 
(5) 
0.8% 
0.3% 0 
(1) 
0.4% 
0 
(6) 
0.4% 
abcde Within each row, numbers with different letter superscripts are significantly different from each 
other, numbers with the same letter superscript are not significantly different (p<0.05) 
Legend:    »SBT«: single blastocyst transfer 
 »DBT«: double blastocyst transfer 
 »SET«: single cleavage stage embryo transfer 
 »DET«: double cleavage stage embryo transfer 
 »TET«: triple cleavage stage embryo transfer 
Table 3. Embryo cultivation strategies and clinical outcome 
The detailed investigation of the incidence of multiple gestations reveals that the incidence 
of higher order multiple pregnancies was low, as only 6 triplet pregnancies were observed 
during the ten-year study period. Conversely, birth of twins was recorded in 22.8% of 
deliveries and as mentioned before, this was especially high in the transfer of two 
blastocysts. In our publications, it was demonstrated that the age of the female patient and 
additional spare blastocysts available for cryopreservation are an important risk factor for 
multiple gestation after blastocyst transfer (Vlaisavljević et al., 2004). Our current data has 
shown, that even in the group of patients older than 40 years, after double blastocyst 
transfer, there were 27.7% twin gestations. This exemplifies the fact that the only option to 
minimize the risk of multiple gestations is strict implementation of single embryo transfer, 
even in the case of dealing with older patients. 
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5. Conclusion 
Introduction of exogenous gonadotrophins to ovarian stimulation represents one of the 
most important events in MAR that substantially improved the results of infertility 
treatment. The first successful pregnancies achieved with MAR were the result of a natural 
cycle IVF. Since then, ovarian stimulation protocols using GnRH agonists or antagonists in 
the combination with recombinant or highly purified gonadotrophins have become an 
everyday routine in MAR practice. Our results show that current protocols of ovarian 
stimulation should be used in a way to avoid excessive follicular development and to 
achieve moderate stimulation of the ovaries. This approach provides superior results 
compared to either aggressive or mild stimulation protocols. According to our study, oocyte 
pick-up resulting in eleven to fifteen harvested oocytes presents the optimal outcome of 
ovarian stimulation. Day five blastocyst transfer enables for higher pregnancy rates 
compared to transfer of cleavage stage embryos, especially when high number of developed 
embryos is available on day three after oocyte pick-up. Extended blastocyst culture also 
allows for transfer of reduced number of embryos without decreasing the overall pregnancy 
rate. However, only strict implementation of single embryo transfer can lead to a decrease in 
the incidence of multiple gestations. These steps, coupled with successful laboratory embryo 
cryopreservation programme, present as an optimal choice for MAR. 
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